News Focus
News Focus
Followers 56
Posts 4233
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Saturday, 04/11/2026 10:37:32 AM

Saturday, April 11, 2026 10:37:32 AM

Post# of 518970
A reason to use the existing Anavex trial data is with Alzheimer’s, the understanding of its cause and diagnosis is still unsettled Science. A work in progress. As such, Anavex has plumbed to greater depths than the cursory explanations regarding plaques etc., addressing the root cause and systems affecting the disease.

In establishing end points to satisfy a regulatory agency that currently doesn’t understand the disease, 3 years in the future, wouldn’t be productive. One of the reasons for Anavex’s current situation.

I think Anavex has the most understanding and practical application regarding Alzheimer’s of any agency in the World.


All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News